HomeInsightsStock Comparison

Sun Pharmaceuticals Industries Ltd vs Zydus Lifesciences Ltd Stock Comparison

Sun Pharmaceuticals Industries Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Aug 05, 2025

Key Highlights

  • The Latest Trading Price of Sun Pharmaceutical Industries Ltd is ₹ 1632 as of 05 Aug 10:52.
  • The P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 19.7 on March 2025 . This represents a CAGR of -2.76% over 6 years.
  • The Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 89122 crore on March 2025 . This represents a CAGR of 21.76% over 6 years.
  • The revenue of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 14315 crore as compare to the Mar '25 revenue of ₹ 13571 crore. This represent the growth of 5.48% The revenue of Zydus Lifesciences Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 6608 crore. This represent the decline of -100%.
  • The ebitda of Sun Pharmaceutical Industries Ltd for the Jun '25 is ₹ 3948 crore as compare to the Mar '25 ebitda of ₹ 3967 crore. This represent the decline of -0.48% The ebitda of Zydus Lifesciences Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 1986 crore. This represent the decline of -100%.
  • The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2302 crore over 9 quarters. This represents a CAGR of 6.16% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 19.16 % on March 2025 . This represents a CAGR of -4.57% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma drops after Q1 PAT slips 20% YoY to Rs 2,279 cr

The drop in profit was primarily due to a one-time exceptional charge of Rs 818 crore duri...

Read more

31 Jul 2025 15:46

News

Sun Pharmaceutical Industries Ltd spurts 0.66%, up for five straight sessions

Sun Pharmaceutical Industries Ltd rose for a fifth straight session today. The stock is qu...

Read more

29 Jul 2025 13:00

News

Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies

Sun Pharmaceutical Industries announced top-line results from two Phase 3 clinical studies...

Read more

21 Jul 2025 09:05

News

Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is qu...

Read more

15 Jul 2025 13:05

News

Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp

The drug is indicated for the treatment of alopecia areata ' a condition in which the immu...

Read more

15 Jul 2025 15:41

News

Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now ava...

Read more

14 Jul 2025 16:48

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences announces board meeting date

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Augu...

Read more

02 Aug 2025 09:52

News

Zydus Lifesciences Ltd soars 1.46%, gains for fifth straight session

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at R...

Read more

29 Jul 2025 13:00

News

Zydus Lifesciences gets USFDA Nod for Ibrutinib tablets

Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic...

Read more

24 Jul 2025 13:16

News

Zydus receives USFDA tentative approval for Ibrutinib tablets

Zydus Lifesciences has received tentative approval from the United States Food and Drug Ad...

Read more

24 Jul 2025 14:38

News

Zydus' Matoda facility completes Remote Regulatory Assessment of USFDA

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA)...

Read more

16 Jul 2025 17:55

News

Zydus Lifesciences gets USFDA Nod for Celecoxib Capsules

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones ...

Read more

15 Jul 2025 15:45

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Sun Pharmaceutical Industries Ltd or Zydus Lifesciences Ltd?

Market cap of Sun Pharmaceutical Industries Ltd is 393,730 Cr while Market cap of Zydus Lifesciences Ltd is 96,568 Cr

What are the key factors driving the stock performance of Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd?

The stock performance of Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd?

As of August 5, 2025, the Sun Pharmaceutical Industries Ltd stock price is INR ₹1641.0. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹959.7.

How do dividend payouts of Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Sun Pharmaceutical Industries Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions